VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Theophylline Treatment for Pseudohypoparathyroidism

Phase 2

Recruiting

Conditions: Pseudohypoparathyroidism
Albright Hereditary Osteodystrophy

Interventions: Drug: Theophylline
Drug: Placebos

First Posted Date: 2017-01-24

Last Posted Date: 2024-04-02

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 34

Registration Number: NCT03029429

Locations: 🇺🇸
Ashley Shoemaker, Nashville, Tennessee, United States

Autonomic Blockade and Endogenous Glucose Production

Phase 1

Withdrawn

Conditions: Insulin Resistance

Interventions: Other: Saline
Drug: Trimethaphan

First Posted Date: 2017-01-23

Last Posted Date: 2021-06-08

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT03028571

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial

Not Applicable

Completed

Conditions: Respiratory Failure With Hypoxia
Respiratory Failure
Endotracheal Intubation

Interventions: Other: No Manual Ventilation
Other: Manual Ventilation

First Posted Date: 2017-01-20

Last Posted Date: 2018-09-13

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 401

Registration Number: NCT03026322

Locations: 🇺🇸
Ochsner Health System, New Orleans, Louisiana, United States
🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Louisiana State University School of Medicine, New Orleans, Louisiana, United States

and more 2 locations

Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids

Phase 1

Completed

Conditions: Glucose Intolerance
Glucocorticoids Toxicity

Interventions: Drug: Prednisone

First Posted Date: 2017-01-18

Last Posted Date: 2020-06-04

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 25

Registration Number: NCT03023891

Locations: 🇺🇸
Vanderbilt University Medical Center -CRC, Nashville, Tennessee, United States

Palliative Care for Non-Malignant Diseases (COMPASS Trial)

Not Applicable

Terminated

Conditions: Liver Diseases
Liver Cirrhosis
NASH (Non-Alcoholic Steatohepatitis)

Interventions: Other: Comprehensive Palliative Care services
Other: Usual hepatic care

First Posted Date: 2017-01-16

Last Posted Date: 2019-11-22

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 63

Registration Number: NCT03022630

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Racial Differences in Vagal Control of Glucose Homeostasis, Chronic Study

Phase 1

Withdrawn

Conditions: Insulin Sensitivity
Oxidative Stress

Interventions: Drug: Galantamine
Drug: Placebo

First Posted Date: 2017-01-09

Last Posted Date: 2018-08-13

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT03014323

Locations: 🇺🇸
Cyndya Shibao, Nashville, Tennessee, United States

CD36 in Nutrient Delivery and Its Dysfunction

Phase 1

Completed

Conditions: Insulin Resistance
Endothelial Dysfunction

Interventions: Drug: Sildenafil Citrate in G allele carrier
Drug: Sildenafil Citrate in non G allele carrier

First Posted Date: 2017-01-06

Last Posted Date: 2022-11-30

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 26

Registration Number: NCT03012386

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

Phase 2

Withdrawn

Conditions: Heart Failure NYHA Class III
Heart Failure NYHA Class II
Heart Failure NYHA Class I

Interventions: Drug: Valsartan 80 mg bid
Drug: Enalapril 10 mg bid
Drug: Sacubitril-Valsartan 200 mg bid
Drug: Icatibant
Drug: Placebo

First Posted Date: 2016-12-29

Last Posted Date: 2018-01-11

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT03005184

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Examination of Cognitive Function in Obesity and Following Weight Loss

Withdrawn

Conditions: Bariatric Surgery Candidate
Obesity
Weight Loss

Interventions: Other: Medical Weight Loss Program
Procedure: Bariatric Surgery

First Posted Date: 2016-12-15

Last Posted Date: 2018-09-27

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT02994186

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Phase 3

Terminated

Conditions: Stevens-Johnson Syndrome
Toxic Epidermal Necrolyses

Interventions: Drug: Harmonized supportive care
Drug: Etanercept 50 mg sc day 1 and day 4

First Posted Date: 2016-12-08

Last Posted Date: 2025-01-07

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 2

Registration Number: NCT02987257

Locations: 🇺🇸
University of California, Davis Medical Center, Sacramento, California, United States
🇺🇸
Valleywise Health Medical Center, Phoenix, Arizona, United States
🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States

and more 11 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy